BAQSIMI Trademark

Trademark Overview

On Friday, March 9, 2018, a trademark application was filed for BAQSIMI with the United States Patent and Trademark Office. The USPTO has given the BAQSIMI trademark a serial number of 87828329. The federal status of this trademark filing is REGISTERED as of Tuesday, November 10, 2020. This trademark is owned by Eli Lilly and Company. The BAQSIMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction
baqsimi

General Information

Serial Number87828329
Word MarkBAQSIMI
Filing DateFriday, March 9, 2018
Status700 - REGISTERED
Status DateTuesday, November 10, 2020
Registration Number6195596
Registration DateTuesday, November 10, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements

Description of MarkThe mark consists of a triangle shape surrounded by lines of different lengths to form a circular firework appearance centered above the word "baqsimi".
Goods and ServicesPharmaceutical preparations, namely, glucagon for diabetes related hypoglycemia, including low blood sugar, diabetes insulin shock, and insulin reaction
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 16, 2018
Primary Code005
First Use Anywhere DateTuesday, August 6, 2019
First Use In Commerce DateTuesday, August 6, 2019

Trademark Owner History

Party NameAMPHASTAR PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRANCHO CUCAMONGA, CA 91730
Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 23, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 10, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, October 7, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 6, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 1, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 16, 2020USE AMENDMENT FILED
Wednesday, September 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 16, 2020TEAS STATEMENT OF USE RECEIVED
Friday, September 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2020SOU EXTENSION 4 GRANTED
Wednesday, September 2, 2020SOU EXTENSION 4 FILED
Wednesday, September 2, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, February 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2020SOU EXTENSION 3 GRANTED
Monday, February 10, 2020SOU EXTENSION 3 FILED
Monday, February 10, 2020SOU TEAS EXTENSION RECEIVED
Saturday, July 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2019SOU EXTENSION 2 GRANTED
Thursday, July 25, 2019SOU EXTENSION 2 FILED
Thursday, July 25, 2019SOU TEAS EXTENSION RECEIVED
Friday, February 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 30, 2019SOU EXTENSION 1 GRANTED
Wednesday, January 30, 2019SOU EXTENSION 1 FILED
Wednesday, January 30, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, September 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 12, 2018ASSIGNED TO EXAMINER
Saturday, March 17, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 13, 2018NEW APPLICATION ENTERED

Related Keywords

baqsimi diabetes insulin blood sugar reaction including shock hypoglycemia preparations namely